We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Biopharmaceutical giant Amgen broke ground this week on a $200 million next-generation biopharma manufacturing plant located at its campus in West Greenwich, Rhode Island.